Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative roxadustat for prevention of postoperative complications after major noncardiac surgery
ACTRN12624000188538Phase 2Active, not recruiting
- Sponsor
- Royal Perth Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in complications of surgical procedures and surgical site infection (SSI) comparing Roxadustat with Placebo (2 arms). Primary endpoints: Postoperative complications within 30 days of surgery meeting Standardised Endpoints in Perioperative Medicine (StEP) definitions and Patient-reported preoperative adverse events. Started Jun 2024; status: active, not recruiting.
02
Drugs
roxadustat
03
Conditions
complications of surgical proceduressurgical site infection (SSI)
Beyond the preview
Go deeper on ACTRN12624000188538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000188538.